Additional file 8: Figure S7. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells [stub]

Amani Moraya, Jennifer Ali, Pranati Samadder, Lisa Liang, Ludivine Morrison, Tamra Werbowetski-Ogilvie, Makanjuola Ogunsina, Frank Schweizer, Gilbert Arthur, Mark Nachtigal
2017 Figshare  
Viability of primary EOC183A cells treated with GAELs alone or pretreated with the pan-caspase inhibitor QVD. No significant difference in cell viability was observed in the presence of QVD, with the exception of the cisplatin positive control. * significantly different from vehicle control; + significantly different from cisplatin alone; pâ
doi:10.6084/m9.figshare.c.3778562_d8.v1 fatcat:tahshe3plrc6db3mjki7bmuvrq